Derivation of Neural Stem Cells from Human Parthenogenetic Stem Cells
We have previously shown that human parthenogenetic stem cells (hpSC) can be chemically directed to differentiate into a homogeneous population of multipotent neural stem cells (hpNSC) that are scalable, cryopreservable, express all the appropriate neural markers, and can be further differentiated into functional dopaminergic neurons. Differentiation of hpSC into hpNSC provides a platform to study the molecular basis of human neural differentiation, to develop cell culture models of neural disease, and to provide neural stem cells for the treatment of neurodegenerative diseases. Additionally, the hpNSC that are generated could serve as a platform for drug discovery and the determination of pharmaceutical-induced neural toxicity. Here, we describe in detail the stepwise protocol that was developed in our laboratory that facilitates the highly efficient and reproducible differentiation of hpSC into hpNSC.
Key wordsParthenogenetic stem cells Pluripotent Differentiation Neural stem cells Transplantation
- 2.Revazova ES, Turovets NA, Kochetkova OD, Agapova LS, Sebastian JL, Pryzhkova MV, Smolnikova VI, Kuzmichev LN, Janus JD (2008) HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 10(1):11–24. https://doi.org/10.1089/clo.2007.0063PubMedCrossRefGoogle Scholar
- 7.Zhou J, Su P, Li D, Tsang S, Duan E, Wang F (2010) High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 28(10):1741–1750. https://doi.org/10.1002/stem.504PubMedPubMedCentralCrossRefGoogle Scholar
- 8.Gonzalez R, Garitaonandia I, Crain A, Poustovoitov M, Abramihina T, Noskov A, Jiang C, Morey R, Laurent LC, Elsworth JD, Snyder EY, Redmond DE Jr, Semechkin R (2015) Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's disease. Cell Transplant 24(4):681–690. https://doi.org/10.3727/096368915X687769PubMedCrossRefGoogle Scholar
- 9.Gonzalez R, Garitaonandia I, Poustovoitov M, Abramihina T, McEntire C, Culp B, Attwood J, Noskov A, Christiansen-Weber T, Khater M, Mora-Castilla S, To C, Crain A, Sherman G, Semechkin A, Laurent LC, Elsworth JD, Sladek J, Snyder EY, Redmond DE Jr, Kern RA (2016) Neural stem cells derived from human parthenogenetic stem cells engraft and promote recovery in a nonhuman primate model of Parkinson’s disease. Cell Transplant. https://doi.org/10.3727/096368916X691682PubMedCrossRefGoogle Scholar
- 10.ClinicalTrials.gov (2016) A study to evaluate the safety of neural stem cells in patients with parkinson’s disease. https://clinicaltrials.gov/ct2/show/NCT02452723